Saturday, September 5, 2026
RSS

Markets & Money

August Jobs Report Fuels Fed Rate-Hike Speculation: What It Means for Investors

The August jobs report stirs Fed rate-hike speculation, impacting Treasury yields and equity valuations, particularly for high-duration growth stocks.

By Marcus Rivera • September 4, 2026
Tech

SoundHound AI's Acquisition of LivePerson: Implications for the Tech Market

Analyzing SoundHound AI's acquisition of LivePerson and its impact on the conversational AI landscape.

Sarah Chen • Sep 4
Pharmaceutical

Moderna and Merck's mRNA Cancer Vaccine Trial: A Turning Point for Biotech Investors

The Phase 3 INTerpath-001 trial results could reshape oncology market dynamics for Moderna and Merck, opening new revenue streams.

James McAllister • Sep 4
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Energy

Record Diesel Prices Raise Inflation Concerns in North American Markets

Soaring diesel prices driven by geopolitical conflicts are stirring inflation fears across North America, impacting mult…

Marcus Rivera • Sep 4, 2026
Pharmaceutical

Merck and Moderna's mRNA Vaccine Triumphs in Melanoma Phase 3 Trials

Merck and Moderna's Phase 3 trial results demonstrate significant advancements in melanoma treatment, impacting stock pe…

Sarah Chen • Sep 4, 2026
Pharmaceutical

Ionis Pharmaceuticals Secures FDA Approval for Groundbreaking Zanvastro Treatment

Ionis Pharmaceuticals' Zanvastro receives FDA approval, marking a significant milestone in the treatment of Alexander di…

James McAllister • Sep 4, 2026
Markets & Money

PayPal's Stock Rises Amid Takeover Speculation: What Investors Should Know

PayPal's stock is seeing upward movement amid takeover talks, fueled by a strong ISM Non-Manufacturing PMI report. Here'…

Marcus Rivera • Sep 3, 2026
Pharmaceutical

AbbVie Expands Immunology Pipeline with $11 Billion Acquisition of Apogee Therapeutics

AbbVie makes a bold move, acquiring Apogee Therapeutics for $11 billion, signaling a strategic push in immunology.

James McAllister • Sep 3, 2026
Pharmaceutical

Moderna's 177% Surge: The Successful Phase 3 Trial That Could Transform Oncology

Moderna's recent Phase 3 trial success has triggered a 177% stock surge, signaling a potential new era in oncology inves…

Marcus Rivera • Sep 3, 2026
Pharmaceutical

Ultragenyx's Dramatic Stock Plunge: What It Means for Rare Disease Biotech Investors

Ultragenyx's stock plummeted 44.7% following the failure of a pivotal trial, raising questions for biotech investors.

Sarah Chen • Sep 3, 2026
Tech

Nvidia's $12.9B Acquisition of Hugging Face: A Game-Changer in the AI Landscape

Nvidia's $12.9 billion acquisition of Hugging Face signals a strategic move in the AI sector, bolstering its software ca…

James McAllister • Sep 3, 2026
Critical Minerals

Greenland Mines Acquires Major Rare Earth Asset: Implications for North American Supply Chains

Greenland Mines' acquisition of a key rare earth asset could reshape North America's critical minerals landscape.

Marcus Rivera • Sep 2, 2026